DBIA
PTX

Dumont & Blake Investment Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,000
Closed -$6K – 192
2016
Q3 		$6K Buy
+1,000
New +$6.16K ﹤0.01% 180

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dumont & Blake Investment Advisors's PTX Position: Q4 2016 in Review

Dumont & Blake Investment Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 1,000 shares — an estimated $6K sold.

Dumont & Blake Investment Advisors first reported a position in PTX in Q3 2016 and held it in 1 quarter. The position peaked at $6K in Q3 2016. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

  • Dumont & Blake Investment Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 1,000 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $6K.
  • Dumont & Blake Investment Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2016 and held it in 1 quarter.
  • Dumont & Blake Investment Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $6K in Q3 2016.
  • 34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Dumont & Blake Investment Advisors's 13F filing for Q4 2016, filed 11 Jan 2017.